Breast cancers devoid of Estrogen Receptor (ER-), Progesterone Receptor (PR-), and HER2 expression (HER2-) are termed Triple-Negative Breast Cancers. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.